Please ensure Javascript is enabled for purposes of website accessibility

Trump Vowed to Dismantle MS-13. His Deal With Bukele Threatens That Effort.

3 hours ago

Ukraine Voices Concern as US Halts Some Missile Shipments

3 hours ago

Poll: Most Americans Say National Divide, Political Violence Threaten Democracy

4 hours ago

Paramount Settles With Trump Over ‘60 Minutes’ Interview for $16 Million

4 hours ago

Republicans Tee up House Vote on Trump Bill, Outcome Uncertain

4 hours ago

What’s Next for Sean ‘Diddy’ Combs After His Sex Trafficking Trial?

4 hours ago

Dalai Lama Says He Will Be Reincarnated, Trust Will Identify Successor

4 hours ago

Shaver Lake and Reedley 4th of July Shows Are Wednesday. Who Else Is Celebrating?

2 days ago
Moderna Asking Regulators to OK Its Virus Shots
gvw_ap_news
By Associated Press
Published 5 years ago on
November 30, 2020

Share

Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens.

Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths. Since first emerging nearly a year ago in China, the virus has killed more than 1.4 million people worldwide.

Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca.

Moderna created its shots with the U.S. National Institutes of Health and already had a hint they were working, but said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.

Of 196 COVID-19 cases so far in its huge U.S. study, 185 were trial participants who received the placebo and 11 who got the real vaccine. The only people who got severely ill — 30 participants, including one who died — had received dummy shots, said Dr. Tal Zaks, the Cambridge, Massachusetts, company’s chief medical officer.

When he learned the results, “I allowed myself to cry for the first time,” Zaks told The Associated Press. “We have already, just in the trial, have already saved lives. Just imagine the impact then multiplied to the people who can get this vaccine.”

Moderna said the shots’ effectiveness and a good safety record so far — with only temporary, flu-like side effects — mean they meet requirements set by the U.S. Food and Drug Administration for emergency use before the final-stage testing is complete. The European Medicines Agency, Europe’s version of FDA, has signaled it also is open to faster “conditional” clearance.

What Comes Next

The FDA has pledged that before it decides to roll out any COVID-19 vaccines, its scientific advisers will publicly debate whether there’s enough evidence behind each candidate.

First up on Dec. 10, Pfizer and BioNTech will present data suggesting their vaccine candidate is 95% effective. Moderna said its turn at this “science court” is expected exactly a week later, on Dec. 17.

Rationing Initial Doses

If the FDA allows emergency use, Moderna expects to have 20 million doses ready for the U.S. by year’s end. Recipients will need two doses, so that’s enough for 10 million people.

Pfizer expects to have 50 million doses globally in December. Half of them — or enough for 12.5 million people — are earmarked for the U.S.

Shipments are set to begin to states within 24 hours of FDA clearance. And this week, a different panel of U.S. experts, established by the Centers for Disease Control and Prevention, will meet to decide how those initial supplies will be given out. They’re expected to reserve scarce first doses for health care workers and, if the shots work well enough in the frail elderly, for residents of long-term care facilities.

As more vaccine gradually becomes available in coming months, other essential workers and people at highest risk from the coronavirus would get in line. But enough for the general U.S. population isn’t expected until at least spring.

Outside the U.S., Zaks said significant supplies from Moderna would be available later, “in the first quarter” of next year.

“Obviously we are doing everything in our power to increase the capacity and accelerate the timelines,” he said.

Britain’s government said Sunday it has ordered 7 million doses from Moderna.

The U.K. also has ordered 40 million doses of the Pfizer-BioNTech vaccine, although it’s not clear how much of the companies’ limited December supply could go toward that order — if British health authorities clear the shots. Still, British hospitals are gearing up to receive some doses as early as next week.

Both Moderna’s and Pfizer’s vaccines are made with the same technology, using a piece of genetic code for the “spike” protein that studs the virus. That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

AstraZeneca Confusion

AstraZeneca and Oxford University last week announced confusing early results of their vaccine candidate from research in Britain and Brazil.

That vaccine appears 62% effective when tested as originally intended, with recipients given two full doses. But because of a manufacturing error, a small number of volunteers got a lower first dose — and AstraZeneca said in that group, the vaccine appeared to be 90% effective.

Experts say it’s unclear why the lower-dose approach would work better and that it may just be a statistical quirk.

A larger U.S. study of the AstraZeneca candidate still is underway that should eventually give the FDA a better picture of how well it works. The FDA has said any COVID-19 vaccine would have to be at least 50% effective.

Meanwhile Britain’s government will have to decide whether its U.K. data is sufficient for an early rollout there.

Still in the Pipeline

Johnson & Johnson also is in final-stage testing in the U.S. and several other countries to see if its vaccine candidate could work with just one dose.

Both the J&J and AstraZeneca vaccines work by using harmless cold viruses to carry the spike protein gene into the body and prime the immune system.

The different technologies have ramifications for how easily different vaccines could be distributed globally. The AstraZeneca shots won’t require freezer storage like the Pfizer and Moderna vaccines.

Candidates made with still other technologies are in late-stage testing, too. Another U.S. company, Novavax Inc., announced Monday that it has finished enrolling 15,000 people in a late-stage study in Britain and plans to begin recruiting even more volunteers for final testing in the U.S. and Mexico “in the coming weeks.”

Vaccines made by three Chinese companies and a Russian candidate also are being tested in thousands of people in countries around the world.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Trump Pulls Back 150 Guard Troops From Federal Duties in California

DON'T MISS

Trump Says Israel Has Agreed to Conditions to Finalize 60-Day Gaza Ceasefire

DON'T MISS

Fresno County Man Arrested for Suspected Arson Hours After Separate Wildfire

DON'T MISS

New California Environmental Rollbacks Could Boost Housing Projects in Fresno

DON'T MISS

Iran Made Preparations to Mine the Strait of Hormuz, US Sources Say

DON'T MISS

Fresno Unified’s Embattled Nikki Henry Exits. ‘I Own My Mistake. I Won’t Let It Own Me.’

DON'T MISS

Trump Floats Daughter-in-Law Lara Trump for Senate Run in North Carolina

DON'T MISS

Google Hit With $314 Million US Verdict in Cellular Data Class Action

DON'T MISS

Tulare County Wildfire Prompts Advisory in Three Rivers Area

DON'T MISS

O’Brien Launches Fresno County Schools Chief Campaign by Handing Out ‘Homework’

UP NEXT

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

UP NEXT

Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters

UP NEXT

US Supreme Court Lets Parents Take Kids Out of Classes With LGBT Storybooks

UP NEXT

Bill Moyers, Broadcaster and LBJ’s White House Press Secretary, Dies at 91

UP NEXT

Tesla Executive, Elon Musk Confidant Leaves EV Maker, Bloomberg News Reports

UP NEXT

How a Birthday Boat Ride on Lake Tahoe Turned Tragic

UP NEXT

Cuomo Concedes to Mamdani in New York City Democratic Mayoral Contest

UP NEXT

Mamdani Holds Lead Over Cuomo in Democratic Primary for NYC Mayor

UP NEXT

Clovis Man Sentenced to 8 Years in Federal Prison in Deadly Fentanyl Case

UP NEXT

Victims Identified as Death Toll Climbs to 8 in Lake Tahoe Boating Tragedy

CHP Officer Dies in Line of Duty After Medical Emergency While on Patrol

1 hour ago

From Victims to Perpetrators: Israeli Soldiers’ Nazi Comparisons and the Unfolding War Crimes in Gaza

2 hours ago

Downtown Housing Could Rise in Many California Cities, but Barriers Remain

2 hours ago

Bryan Kohberger to Plead Guilty to Murders of Four Idaho Students

2 hours ago

Dear Mayor and City Council, Fresno’s Housing Bottlenecks Are a Modern Form of Redlining

3 hours ago

Iran Enacts Law Suspending Cooperation With UN Nuclear Watchdog

3 hours ago

Valley Children’s Goes Into News Business to Highlight Stories at the Hospital

3 hours ago

Trump Vowed to Dismantle MS-13. His Deal With Bukele Threatens That Effort.

3 hours ago

Ukraine Voices Concern as US Halts Some Missile Shipments

3 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Logan Ryan Martin

4 hours ago

Check Out Newest Downtown Mural. It’s a Spectacular Tribute to Fresno Artisans

Fresno Ideaworks is home to a new downtown mural that celebrates those who work with their hands. Instead of a big entrance sign, Ideaworks ...

16 minutes ago

16 minutes ago

Check Out Newest Downtown Mural. It’s a Spectacular Tribute to Fresno Artisans

A drone view of the Rio Grande River between Mexico and the United States in Presidio County, Texas, U.S., February 24, 2025. (Reuters File)
45 minutes ago

US Judge Blocks Trump Asylum Ban at US-Mexico Border, Says He Exceeded Authority

Fresno Fire officials are seeking help identifying a person of interest after a Thursday, June 26, 2025, house fire near Shields and Valentine was ruled arson. (Fresno FD)
1 hour ago

Fresno Fire Investigators Seek Public’s Help in Arson Case

A California Highway Patrol officer died early Wednesday, July 2, 2025, after a suspected medical emergency caused his patrol vehicle to crash in Los Angeles. (CHP)
1 hour ago

CHP Officer Dies in Line of Duty After Medical Emergency While on Patrol

A general view shows destruction in North Gaza, as seen from Israel, May 27, 2025 (REUTERS/Amir Cohen TPX IMAGES OF THE DAY)
2 hours ago

From Victims to Perpetrators: Israeli Soldiers’ Nazi Comparisons and the Unfolding War Crimes in Gaza

San Francisco Housing Development
2 hours ago

Downtown Housing Could Rise in Many California Cities, but Barriers Remain

Bryan Kohberger, right, who is accused of killing four University of Idaho students in November 2022, is escorted into a courtroom to appear at a hearing in Latah County District Court, in Moscow, Idaho, U.S., September 13, 2023. (Reuters File)
2 hours ago

Bryan Kohberger to Plead Guilty to Murders of Four Idaho Students

3 hours ago

Dear Mayor and City Council, Fresno’s Housing Bottlenecks Are a Modern Form of Redlining

Help continue the work that gets you the news that matters most.

Search

Send this to a friend